Sec Form 3 Filing - Northern Genesis Sponsor II LLC @ Embark Technology, Inc. - 2021-01-12

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Northern Genesis Sponsor II LLC 2. Issuer Name and Ticker or Trading Symbol Embark Technology, Inc. [ EMBK] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 4801 MAIN STREET, SUITE 1000 3. Date of Earliest Transaction (MM/DD/YY) 01/12/2021 (Street) KANSAS CITY, MO64112 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 10,350,000( 1 ) I By Northern Genesis Sponsor II LLC( 2 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Warrant $ 11.5 ( 3 ) ( 4 ) Common Stock 5,966,667( 5 ) I By Northern Genesis Sponsor II LLC( 2 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Northern Genesis Sponsor II LLC 4801 MAIN STREET, SUITE 1000 KANSAS CITY, MO64112 X Robertson Ian 4801 MAIN STREET, SUITE 1000 KANSAS CITY, MO64112 X CEO Signatures Northern Genesis Sponsor II LLC, by Ian Robertson, Managing Member 09/21/2022 Signature of Reporting Person Date /s/ Ian Robertson 09/21/2022 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Includes up to 1,350,000 shares that may be forfeited if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full. ( 2 )The shares and warrants are owned directly by the Issuer's sponsor, Northern Genesis Sponsor II LLC (the "Sponsor"). Ian Robertson, the Issuer's Chief Executive Officer and Director, is one of the managing members of the Sponsor. Mr. Robertson disclaims beneficial ownership of the securities held by the Sponsor except to the extent of his pecuniary interest therein. ( 3 )Each warrant will become exercisable on the later of 30 days after the completion of the Issuer's initial business combination or January 15, 2022. ( 4 )Each warrant will expire five years after the completion of the Issuer's initial business combination. ( 5 )Includes warrants which, prior to the effective date of the registration statement relating to the Issuer's initial public offering, the Issuer's Sponsor irrevocably committed to purchase. The purchase of these warrants is being made on a private placement basis and will be consummated simultaneously with the consummation of the Issuer's initial public offering. Does not include up to 720,000 additional warrants which the Issuer's Sponsor irrevocably committed to purchase in the event the underwriters in the Issuer's initial public offering exercise the over-allotment option in full. Each warrant entitles the holder to purchase one share of the Issuer's common stock at a price of $11.50 per share, subject to adjustment.

Remarks: Inadvertently late filing.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.